2023
National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer
HPB (Oxford)
•Cancer Specialist (Oncologist), Surgical Oncologist (Surgical Specialist - Cancer)
Dr. Hughes' research interests center on improving the understanding of gastrointestinal tumor biology through genetic analysis and assessing the response of these historically stubborn tumors to a new class of medications called tyrosine kinase inhibitors.
173 publications
2023
HPB (Oxford)
•2023
Cancers
•2023
Diseases of the colon and rectum
•2023
Microorganisms
•2023
Surgery
•